학술논문

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
Document Type
Article
Source
In: Medicine (United States). (Medicine (United States), 7 October 2022, 101(40):E30871)
Subject
Language
English
ISSN
15365964
00257974